Search
for
Sort by
Research 451–480 of 1000+
- Actions of 5α-reductase inhibitors on the epididymis
- Sex differences in arterial hypertension
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Management of Chemotherapy-Induced Alopecia With Scalp Cooling
- The dermatoscope in the hair clinic: Trichoscopy of scarring and nonscarring alopecia
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Alopecia associated with atorvastatin
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- A phase I study of MK-5108, an oral aurora A kinase inhibitor, in both monotherapy and in combination with docetaxel in patients with advanced solid tumors.
- COVID-19 in Africa: an ovarian victory?
- Methotrexate treatment of generalized granuloma annulare: a retrospective case series
- The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- Janus kinase inhibitors for alopecia areata
- A Plain Language Summary on Ritlecitinib Treatment for Adults and Adolescents with Alopecia Areata
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- Hair Removal Practices: A Literature Review.
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients
- Off-label prescriptions: patient safety first
- Lichen Planopilaris in Children: A Systematic Review
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Alopecia – New building blocks
- Reproductive System, Male
- Vitamins and Hair: Sham or Science?